Early-stage cervical cancer treatment - what's new?

cervical cancer gynaecological cancer hysterectomy laparoscopic approach minimally invasive surgery

Journal

Przeglad menopauzalny = Menopause review
ISSN: 1643-8876
Titre abrégé: Prz Menopauzalny
Pays: Poland
ID NLM: 101263235

Informations de publication

Date de publication:
Jun 2023
Historique:
received: 02 01 2023
accepted: 27 01 2023
medline: 7 9 2023
pubmed: 7 9 2023
entrez: 7 9 2023
Statut: ppublish

Résumé

The gold standard of treatment for patients with early-stage cervical cancer is radical hysterectomy, in agreement with the entire scientific community. During the last decade, growing evidence has supported the minimally invasive approach. Several studies have suggested that the minimally invasive approach could improve surgical and perioperative outcomes. Because of these findings, ESCO/ESTRO/ESP guidelines state that a "minimally invasive approach is favoured" in comparison with open surgery, as a grade B recommendation. Because of the lack of a grade A recommendation, this randomized Laparoscopic Approach to Cervical Cancer trial evaluated open vs. minimally invasive approach in the early stage. It demonstrated an increase in mortality among patients treated with minimally invasive surgery, revolutionizing current thinking on the primary surgical approach to early cervical cancer. The aim of this study is to analyse which is the best treatment for early cervical cancer and which approach is the most effective at the moment. Further studies are needed to state with certainty the appropriateness of the treatments offered to patients with early cervical cancer.

Identifiants

pubmed: 37674927
doi: 10.5114/pm.2023.127774
pii: 50764
pmc: PMC10477763
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

87-92

Informations de copyright

Copyright © 2023 Termedia.

Références

N Engl J Med. 2018 Nov 15;379(20):1955-1957
pubmed: 30379600
Vaccines (Basel). 2022 Apr 09;10(4):
pubmed: 35455328
J Invest Surg. 2021 Jul;34(7):754-755
pubmed: 31818165
Minerva Obstet Gynecol. 2021 Apr;73(2):233-246
pubmed: 33140628
Updates Surg. 2017 Sep;69(3):383-388
pubmed: 28466456
Cancer Med. 2018 Oct;7(10):5217-5236
pubmed: 30589505
J Laparoendosc Adv Surg Tech A. 2015 Dec;25(12):990-8
pubmed: 26584414
J Turk Ger Gynecol Assoc. 2022 Oct 26;23(4):233-240
pubmed: 36285905
J Gynecol Oncol. 2021 Nov;32(6):e83
pubmed: 34431254
Gynecol Oncol. 2006 Dec;103(3):859-64
pubmed: 16806442
Infect Agent Cancer. 2022 Oct 21;17(1):53
pubmed: 36271433
Crit Rev Oncol Hematol. 2019 Nov;143:76-80
pubmed: 31499276
Int J Gynaecol Obstet. 2020 Oct;151(1):43-48
pubmed: 32511745
Updates Surg. 2017 Dec;69(4):441-449
pubmed: 28918603
J Glob Oncol. 2016 May 25;2(5):311-340
pubmed: 28717717
J Natl Compr Canc Netw. 2020 Jun;18(6):660-666
pubmed: 32502976
J Radiat Res. 2021 Mar 10;62(2):269-284
pubmed: 33415337
Int J Gynecol Cancer. 2019 Nov;29(9):1355-1360
pubmed: 31422352
Int J Gynaecol Obstet. 2020 Feb;148(2):174-180
pubmed: 31657456
J Gynecol Oncol. 2018 Jul;29(4):e74
pubmed: 29806249
Eur J Surg Oncol. 2015 Jan;41(1):34-9
pubmed: 25468458
J Minim Invasive Gynecol. 2018 Mar - Apr;25(3):402-410
pubmed: 29191471
Curr Opin Obstet Gynecol. 2020 Feb;32(1):22-27
pubmed: 31815768
Anticancer Res. 2014 Oct;34(10):5703-8
pubmed: 25275077
J Minim Invasive Gynecol. 2021 Jan;28(1):117-123
pubmed: 32320800
Int J Environ Res Public Health. 2022 Sep 15;19(18):
pubmed: 36141917
Arch Gynecol Obstet. 2019 Feb;299(2):299-315
pubmed: 30542793
J Minim Invasive Gynecol. 2014 Sep-Oct;21(5):857-62
pubmed: 24699300
BJOG. 2021 Dec;128(13):2213-2214
pubmed: 34402585
J Gynecol Oncol. 2017 Nov;28(6):e82
pubmed: 29027400
Oncology. 2015;89(2):103-10
pubmed: 25924602
Eur J Obstet Gynecol Reprod Biol. 2022 Aug;275:64-69
pubmed: 35753229
J Invest Surg. 2022 Jun;35(6):1392-1393
pubmed: 35343352
J Minim Invasive Gynecol. 2016 Jan;23(1):14-5
pubmed: 26386388
J Psychosom Obstet Gynaecol. 2017 Mar;38(1):85-86
pubmed: 27750481
Oncol Res Treat. 2016;39(9):508-14
pubmed: 27614875
J Gynecol Oncol. 2019 Mar;30(2):e27
pubmed: 30740958
J Pain Symptom Manage. 2015 Feb;49(2):258-64
pubmed: 24996034
Int J Environ Res Public Health. 2022 Oct 13;19(20):
pubmed: 36293758
Lancet. 2019 Jan 12;393(10167):169-182
pubmed: 30638582
Int J Gynecol Cancer. 2015 Mar;25(3):493-7
pubmed: 25628110
Healthcare (Basel). 2022 Aug 24;10(9):
pubmed: 36141217
Tumori. 2017 Jan 21;103(1):76-80
pubmed: 27716879
J BUON. 2016 Mar-Apr;21(2):320-5
pubmed: 27273940
J Gynecol Oncol. 2017 May;28(3):e34
pubmed: 28382797
Int J Cancer. 2016 Dec 1;139(11):2436-46
pubmed: 27522007
Urology. 2015 Jun;85(6):1252-6
pubmed: 26099869
Gynecol Oncol. 2021 Apr;161(1):173-178
pubmed: 33514481
Gynecol Oncol. 2001 Jan;80(1):3-12
pubmed: 11136561
Gynecol Oncol. 2006 Sep;102(3):563-72
pubmed: 16716379
Virchows Arch. 2018 Jun;472(6):919-936
pubmed: 29725757
Minim Invasive Ther Allied Technol. 2023 Feb;32(1):1-11
pubmed: 36512487
Lancet Oncol. 2020 Jun;21(6):851-860
pubmed: 32502445
J Surg Oncol. 2014 Dec;110(7):893-8
pubmed: 25132470
Diagnostics (Basel). 2022 Nov 13;12(11):
pubmed: 36428831
Int J Gynaecol Obstet. 2021 Oct;155 Suppl 1:28-44
pubmed: 34669203
BMC Cancer. 2015 Nov 24;15:928
pubmed: 26596955
Ann Surg Oncol. 2016 Jul;23(7):2176-82
pubmed: 26597364
Int J Gynecol Cancer. 2020 Jul;30(7):987-992
pubmed: 32448809
Am J Obstet Gynecol. 2020 Mar;222(3):249.e1-249.e10
pubmed: 31586602
Surg Endosc. 2015 May;29(5):1231-9
pubmed: 25673344
J Clin Med. 2022 Nov 25;11(23):
pubmed: 36498515
J Cancer Res Ther. 2017 Jul-Sep;13(3):598-599
pubmed: 28862236
Gynecol Obstet Invest. 2022;87(3-4):242-247
pubmed: 35584619
J Invest Surg. 2022 Jul;35(7):1602-1603
pubmed: 35549629
Int J Gynecol Cancer. 2014 May;24(4):787-93
pubmed: 24552894
Am J Obstet Gynecol. 2008 Jan;198(1):99.e1-7
pubmed: 18166319
J Natl Compr Canc Netw. 2013 Mar 1;11(3):320-43
pubmed: 23486458
Gynecol Oncol. 2022 Sep;166(3):561-566
pubmed: 35909005
Int J Environ Res Public Health. 2022 Jun 09;19(12):
pubmed: 35742340
Acta Obstet Gynecol Scand. 2019 Nov;98(11):1398-1403
pubmed: 31242322
J Clin Med. 2022 Jun 10;11(12):
pubmed: 35743403
Lancet Oncol. 2019 Sep;20(9):1198-1199
pubmed: 31383546
N Engl J Med. 2018 Nov 15;379(20):1895-1904
pubmed: 30380365

Auteurs

Camilla Di Dio (CD)

Department of Maternal and Child Health and Urological Sciences, Sapienza University of Rome, Policlinico Umberto I, Rome, Italy.

Ilham Azenkoud (I)

Department of Maternal and Child Health and Urological Sciences, Sapienza University of Rome, Policlinico Umberto I, Rome, Italy.

Angelo Trezza (A)

Department of Maternal and Child Health and Urological Sciences, Sapienza University of Rome, Policlinico Umberto I, Rome, Italy.

Emanuele Lentini (E)

Department of Maternal and Child Health and Urological Sciences, Sapienza University of Rome, Policlinico Umberto I, Rome, Italy.

Tullio Golia D'Augè (TG)

Department of Maternal and Child Health and Urological Sciences, Sapienza University of Rome, Policlinico Umberto I, Rome, Italy.

Ilaria Cuccu (I)

Department of Maternal and Child Health and Urological Sciences, Sapienza University of Rome, Policlinico Umberto I, Rome, Italy.

Giorgia Di Bartolomeo (GD)

Department of Maternal and Child Health and Urological Sciences, Sapienza University of Rome, Policlinico Umberto I, Rome, Italy.

Ilaria Firulli (I)

Department of Maternal and Child Health and Urological Sciences, Sapienza University of Rome, Policlinico Umberto I, Rome, Italy.

Andrea Canicchio (A)

Department of Maternal and Child Health and Urological Sciences, Sapienza University of Rome, Policlinico Umberto I, Rome, Italy.

Ludovica Sgamba (L)

Department of Maternal and Child Health and Urological Sciences, Sapienza University of Rome, Policlinico Umberto I, Rome, Italy.

Ludovico Muzii (L)

Department of Maternal and Child Health and Urological Sciences, Sapienza University of Rome, Policlinico Umberto I, Rome, Italy.

Classifications MeSH